Get notified when ROG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRisk Profile Improvements
- Goodwill Impairment (removed) — The $67.3 million curamik goodwill impairment from Q2 2025 is absent from the current period, reflecting a one-time prior-year charge rather than a new impairment.
revenue $216.8M, net income $13.6M. Rogers swings to Q2 profit as sales rise 6.9% and impairment charges vanish
Filed July 29, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 1, 2025 · ~1 min read
Key Changes
-
high
Net sales rose 6.9% to $216.8 million, with gross margin up 90 basis points to 32.5%.
MD&A: Net Sales verify on EDGAR → -
medium
Share repurchases slowed to $3.0 million, leaving $48.8 million under the $200 million authorization.
Controls: Share Repurchases verify on EDGAR → -
medium
Asbestos claims outstanding fell to 389 from 488, with higher dismissals and settlements.
Legal Proceedings verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.
Partner
Trade ROG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 7, 2026 · How we verify